Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer
Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3
MADISON, N.J., Feb. 26, 2014 -- (Healthcare Sales & Marketing Network) -- Quest Diagnostics (DGX), the wor... Diagnostics, Oncology, Product LaunchQuest Diagnostics, Lynch syndrome, hereditary nonpolyposis colorectal cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Hereditary Nonpolyposis Colorectal Cancer | HNPCC | Lynch Syndrome | Marketing | Pharmaceuticals